Aemetis, Inc (NASDAQ:AMTX – Get Free Report) Director Timothy Alan Simon sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $2.05, for a total transaction of $20,500.00. Following the transaction, the director owned 42,632 shares of the company’s stock, valued at approximately $87,395.60. This represents a 19.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Aemetis Trading Down 2.5%
NASDAQ AMTX opened at $1.96 on Friday. The firm has a market cap of $137.93 million, a price-to-earnings ratio of -1.65 and a beta of 1.36. The company has a 50 day moving average of $2.55 and a 200-day moving average of $2.02. Aemetis, Inc has a 1-year low of $1.30 and a 1-year high of $3.80.
Aemetis (NASDAQ:AMTX – Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The specialty chemicals company reported ($0.33) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.06). The company had revenue of $54.62 million for the quarter, compared to analyst estimates of $66.70 million. On average, analysts forecast that Aemetis, Inc will post -1.11 earnings per share for the current year.
Institutional Investors Weigh In On Aemetis
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on AMTX shares. Loop Capital set a $1.75 price target on shares of Aemetis in a research report on Thursday, March 12th. Wall Street Zen cut shares of Aemetis from a “hold” rating to a “sell” rating in a research report on Saturday, June 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research report on Monday, April 20th. Finally, Ascendiant Capital Markets boosted their price objective on shares of Aemetis from $21.00 to $22.00 and gave the company a “buy” rating in a research report on Friday, May 22nd. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Aemetis presently has a consensus rating of “Hold” and an average target price of $8.92.
View Our Latest Report on AMTX
Aemetis Company Profile
Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.
Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.
Featured Stories
- Five stocks we like better than Aemetis
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.
